CLEAR LABELS Act

The CLEAR LABELS Act (S 3788) requires drug manufacturers, packers, and distributors to label finished drugs and active pharmaceutical ingredients with specific supply chain information. This includes the name, location, and unique facility ID of the original manufacturer for both active ingredients and finished products, either directly on labels or via QR codes/link to an electronic portal. The bill directly affects drug companies and distributors by mandating clearer labeling to trace products through the supply chain. It also exempts compliant drugs from separate customs country-of-origin marking requirements. These changes aim to improve transparency for consumers and regulators about drug origins.